Viewing nowCombinationTelmisartan and Rosuvastatin Tablets 40/10 mg
Telmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202101798 · Approved 2021.02.23 · Insurance code 643308710
Treatment of hypertension and dyslipidemia; prevention of cardiovascular disease; inhibition of atherosclerosis progression
This medication is indicated for patients who need to take both telmisartan and rosuvastatin. Telmisartan is mainly used for the treatment of essential hypertension and for reducing the risk of cardiovascular diseases, particularly in high-risk patients where ACE inhibitors cannot be used to lower the risks of myocardial infarction, stroke, and cardiovascular mortality. Rosuvastatin helps to improve hypercholesterolemia and dyslipidemia, and is used as an adjunct when dietary modifications are inadequate. It also slows the progression of atherosclerosis in patients with hypercholesterolemia and reduces the risk of stroke and myocardial infarction in certain high-risk patients. The combination of these two drugs aids in effectively managing hypertension and dyslipidemia and reducing the risk of cardiovascular diseases.
In a drug interaction study of the active ingredients of this medicine, telmisartan 80mg and rosuvastatin 20mg, telmisartan Cmax increased by approximately 1.35-fold and AUC by approximately 1.17-fold in the presence of rosuvastatin, while rosuvastatin Cmax increased by approximately 2-fold and AUC by approximately 1.18-fold in the presence of telmisartan. Therefore, when administering this medicine, assess the potential risk associated with the increase in rosuvastatin Cmax and monitor the patient closely. This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg orally once daily as telmisartan; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medicine is coadministered with a thiazide diuretic such as hydrochlorothiazide, it has an additional blood pressure-lowering effect. When the dose is increased, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication may cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals with hypersensitivity to this medication, pregnant women, nursing women, or fertile women not using appropriate contraception. Caution is required when administering this medication to patients with severe liver impairment or issues with bile excretion. In patients with a history of muscle disease or severe renal failure, use may be prohibited or require careful observation. Elderly patients, patients with hyperkalemia, and patients with mild liver impairment should use this medication with special caution. If muscle pain or weakness occurs, consult a physician immediately, and in severe cases, discontinue use. Regular monitoring of liver function tests and blood enzyme levels is necessary; if abnormalities are detected, discontinuation may be warranted. This medication may interact with other drugs, so if you are taking any other medications, inform your physician or pharmacist. Caution is necessary while driving or operating machinery as dizziness may occur. It is not recommended for children, as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, dizziness, and renal impairment may occur, so immediate medical attention is necessary. This drug should be kept out of the reach of children and should not be transferred to another container.
Elevated ALT, elevated AST, elevated serum creatine phosphokinase (CPK), dizziness, itching, dyspepsia, oral sensory disturbance, musculoskeletal stiffness, acne, nasopharyngitis, increased serum potassium, glycosuria, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disorder, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, pharyngitis, sinusitis, urinary tract infection, cystitis, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, abdominal distension, vomiting, abdominal discomfort, dry mouth, liver dysfunction, liver disorders, increased sweating, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, back pain, muscle cramps, joint pain, limb pain, tendon pain, acute kidney failure, chest pain, weakness, influenza-like illness, elevated serum creatinine, elevated serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, headache, facial spasms, sensory disturbances, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, decreased libido, facial swelling, alopecia, conjunctivitis, tinnitus, petechiae, constipation, nausea, pancreatitis, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthritis, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, sexual dysfunction, gynecomastia, interstitial lung disease, fatal and non-fatal liver failure, headache, cough, palpitations, fatigue, nausea, insufficient effect, joint pain, numbness, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air or moisture. It is best to keep it at room temperature between 1°C and 30°C.
Light orange oval film-coated tablets
30 tablets/box [(10 tablets/PTPX3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.